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CLINICAL & BASIC RESEARCH
abstract: Objectives: This study aimed to analyse the stages of lung tissue damage caused by exposure to 
electronic cigarette (e-cigarette) smoke. The negative health effects of e-cigarettes remain debatable. Several studies 
have shown the adverse effects, but others opine that e-cigarettes are safer to use than their tobacco counterparts. 
There is, however, a possibility that the long-term health effects, such as respiratory and even kidney function 
impairment, are presently not obvious. The amounts of increased free radicals and pro-inflammatory cytokines 
from e-cigarettes result in various physiological disorders, which trigger cell damage and even cell death in the 
body. Methods: An experimental study was conducted between March and September 2019 in Airlangga University 
using a control and an experimental group of male Wistar rats to assess the levels of malondialdehyde, interleukin 
(IL)-8, IL-10, matrix metalloprotein-8 and type-2 collagen. The results were obtained using immunohistochemical 
staining methods on alveolar macrophages through Hematoxylin-Eosin staining. Results: The results showed that 
exposure to e-cigarette smoke caused an increase in free radicals, triggered an inflammatory process and degraded 
the type-2 collagen present in the lung tissue. Conclusion: Exposure to e-cigarette smoke can cause cell damage 
in lung tissues.
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Advances in Knowledge
- This study explains the mechanism of lung tissue damage due to exposure to electronic cigarette (e-cigarette) smoke from the airway to 
the cells of lung tissues.
- The damage caused by e-cigarettes reaches the type-2 collagen, which indirectly affects the cartilages of the respiratory tract.
Application to Patient Care
- This research aims to analyse the impact of the damage caused by e-cigarettes to enable its use as a reference in educating the public to 
avoid or reduce using them.
The use of electronic cigarettes (e-cigarettes) increases every year. They are usually advertised as products that have 
low nicotine levels and are often seen as a viable 
alternative to smoking cessation. Consequently, most 
people believe e-cigarettes are safer than their tobacco 
counterparts.1 In addition, aggressive marketing from 
e-cigarette producers accelerates and increases its use 
among users.2 While various studies have shown the 
short-term adverse effects, such as an increase in free 
radicals and/or respiratory/airway inflammation, the 
long-term risks of exposure and use remain unknown 
because it is still a recent innovation.3,4 However, 
various physiological disorders arising from cell 
damage caused by e-cigarette smoke pose a safety 
concern.5
The e-cigarette is an electronic device that 
utilises battery power.6 Its use is different from 
tobacco cigarettes, which require the burning of 
natural tobacco leaves. It involves a heating process 
conducted on metals containing a liquid, either 
nicotine, propylene glycol or vegetable glycerol, which 
is used as a solvent or flavour.6 The metal and the 
liquid are heated to give off steam that is inhaled by the 
user. The various types of metals and materials used 
in the manufacturing process of these e-cigarettes 
increasingly raise concerns regarding its level of safety 
for users.7 The resulting steam produced also causes 
inflammation in the airways, reduces immunological 
defence and triggers lung tissue damage.8 
E-Cigarettes contain high concentrations of 
free radicals that are approximately 1016 molecules/
puff. These free radicals, in turn, consist of reactive 
oxygen species (ROS) and reactive nitrogen species 
(RNS). Upon inhalation, free radicals are neutralised 
by enzymatic antioxidants such as superoxide 
dismutase, glutathione peroxidase and catalase. 
However, when these free radicals are inhaled or 
taken in excess, complete neutralisation will be 
impossible. This would consequently trigger cellular 
damage and inflammatory response through the 
release of pro-inflammatory cytokines by macrophage 
cells.9 One of these cytokines is interleukin-8, which 
plays a role in cellular rupture and damage. Other 
cytokines include the neutrophil chemotactic factor, 
which releases neutrophils into lung tissue. Increased 
interleukin (IL)-8 secretion will stimulate the release 
of a metalloprotein-8 matrix into the lung tissues.10 
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Metalloprotein matrix is an endopeptidase synthesised 
by neutrophils and expressed in various inflammatory 
cells when these neutrophils are activated by different 
inflammatory mediators of cell damage.11 Therefore, 
metalloprotein matrix is not expressed in healthy cells 
or tissues, so it is often a parameter for the diagnosis 
of tissue damage.12 Excessive metalloprotein-8 matrix 
will affect the collagen structure and function in 
respiratory cartilages by increasing the degradation 
of type-2 collagen.13 Such damage occurring in the 
lung tissue for an extended amount of time would 
increase the risk of pulmonary fibrosis. This would 
render the tissue damage irreversible and result in 
various diseases, including pulmonary hypertension, 
cardiovascular problems and lung cancer.14
This study aims to determine the stages of lung 
tissue damage through increased free radicals and 
inflammatory responses; these indirectly result in 
increased numbers of alveolar macrophages that 
cause damage to lung tissues. This research was done 
by comparing a group of experimental animals (male 
Wistar rats) that were exposed to e-cigarette smoke to 
a control group.
Methods
In this study conducted between March and 
September 2019 in Airlangga University, male Wistar 
rats were used because there was’t menstrual cycle in 
the subjects, which signifies no changes in hormone 
levels. During care and maintenance of experimental 
animals, the 3R principle of replacement, refinement 
and reduction was applied. The animals were kept in 
accordance with standard natural conditions of two 
cycles (12 hours of light and 12 hours of dark) and 
provided with healthy food and water. 
E-cigarettes were used in this study, each 
containing 6 mg of nicotine. The liquid was heated 
using a coil made of nickel. The experimental method 
involved streaming smoke into a smoking chamber 
sized 70 × 50 × 30 cm. The rats were included in 
the chamber only when an appropriate smoke 
exposure had been given in accordance with the 
experimental duration. Malondialdehyde, IL-8, IL-
10, metalloprotein-8 matrix and type-2 collagen 
require an immunohistochemistry (IHC) staining 
method for assessment. IHC assesses the expression 
of each sample quantitatively. The values are the 
average numbers of positive cells observed for each 
preparation. The data for each sample is the average 
value of the immunoreactive score observed in 10 
different fields of view (LP) using a magnification of 
400× on a light microscope. 
The histological examination started with the 
removal of pulmonary organs of the rats to make 
preparations for the Hematoxylin-Eosin staining 
method. The assessment involves calculating the mean 
number of alveolar macrophages in 10 visual fields per 
preparation. Observations were carried out under 
objective magnifications of 40× using an immersion 
microscope.
Figure 1: The methodology flowchart of an experimental study conducted on male Wistar rats assessing the levels of 
malondialdehyde (MDA), interleukin (IL)-8, IL-10, matrix metalloprotein-8 (MMP-8) and type-2 collagen following 
electronic-cigarette smoke exposure. 
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In this study, the experiment was divided into 
two groups. The first was the control group, which was 
given only food without any exposure to e-cigarette 
smoke. The second group was given food and exposed 
to e-cigarette smoke for two minutes daily during the 
4-week period of the experiment [Figure 1].
The results of this study were obtained via a 
ratio data focused on the average number of positive 
cells from malondialdehyde, IL-8, IL-10, matrix 
metalloprotein (MMP)-8 and type-2 collagen in the 
lung tissue as well as the mean number of alveolar 
macrophages in each group. Data analysis was 
performed via t-test analysis using Statistical Package 
for the Social Sciences (SPSS), Version 22.0 (IBM 
Corp., Armonk, New York, USA). The next stage of 
the data analysis was performed using the partial least 
square (PLS) test to observe the effects between the 
variables.
This study received ethical approval from the 
Health Research Ethics Committee, Faculty of Public 
Health, Universitas Airlangga.
Results
The results of this study were obtained by comparing 
the average number of positive cells in 10 varying 
LPs between the control and experiment groups for 
malondialdehyde, IL-8, IL-10, MMP-8 and type-2 
collagen. The mean value and standard deviation of 
each variable in both groups are definite. The t-test 
revealed a significant difference in the number of 
positive cells between the control and experiment 
groups [Figures 2a, 2b and 3].
In the experiment group, the number of positive 
cells from malondialdehyde (24.30 ± 0.82), IL-8 (15.49 
± 0.56), IL-10 (6.88 ± 0.35) and the MMP-8 matrix 
(12.01 ± 0.35) were significantly higher than those in 
the control group from malondialdehyde (6.80 ± 0.28), 
IL-8 (5.86 ± 0.27), IL-10 (3.91 ± 0.20) and the MMP-
8 matrix (7.14 ± 0.23). Additionally, the number of 
positive cells of type-2 collagen in the control group 
(14.19 ± 0.47) was significantly higher than those 
in the experiment group (5.26 ± 0.27) [Figure 3]. 
Figure 2: Immersion microscopic scans at 100x magnification showing a higher number of cells positive for 
malondialdehyde as seen in (A) the experiment group compared to (B) the control group of male Wistar rats based on 
positive antigen-antibody reactions expressed through the brownish-black cytoplasm. 
Figure 3: The mean value and standard deviation 
as seen in the experimental group compared to the 
control group of male Wistar rats in a study assessing 
the levels of malondialdehyde, interleukin (IL)-8, IL-10, 
matrix metalloprotein-8 and type-2 collagen following 
electronic-cigarette smoke exposure. 
Figure 4: Immersion microscopic scans at 100x magnification showing a higher number of alveolar macrophage cells as 
seen in (A) the experimental group as compared to (B) the control group of male Wistar rats in a study assessing the levels 
of malondialdehyde, interleukin (IL)-8, IL-10, matrix metalloprotein-8 and type-2 collagen following electronic-cigarette 
smoke exposure.
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The results of this study were obtained by 
comparing the mean number of alveolar macrophages 
per preparation in 10 LP between the control and 
experiment groups [Figures 4a and 4b]. The standard 
deviation and average value of alveolar macrophages 
were observed for each group. T-test results exhibited 
a difference in the number of alveolar macrophages 
between both groups (P <0.001), where the experiment 
group (53.26 ± 0.93) had a greater number of positive 
cells compared to the control group (21.86 ± 1.12) 
[Figure 3].
The results of the correlation test uncovered a 
strong association between malondialdehyde, IL-8, 
IL-10, matrix MMP-8, type-2 collagen and alveolar 
macrophages present in lung tissue (r >0.80) [Table 1].
Discussion
This research shows an increase in various parameters 
that can impact health negatively. It has been observed 
that the content found and inhaled from e-cigarettes will 
cause lung tissue damage. Free radicals passing through 
the airways trigger oxidative stress and set off lipid 
peroxidation, increasing the levels of malondialdehyde, 
as shown in the immunohistochemical micrographs 
[Figures 2 and 4]. E-cigarette smoke that enters and 
passes through the airway will increase the number 
of free radicals.15 When these free radicals become 
excessive or abundant, oxidative stress also increases, 
which causes further lipid peroxidation and cell 
damage.16 The product of a lipid peroxidation reaction 
is malondialdehyde, which is one of the final metabolic 
by-products of peroxidase and hence, a commonly used 
marker of increased free radicals in the body.17 The 
increase in malondialdehyde levels in the experiment 
group in this study was due to free radicals from 
e-cigarettes entering the respiratory tract. 
Cell damage causes cell necrosis, which in 
turn results in cellular debris, often called damage-
associated molecular patterns (DAMPs) in the 
micro-environment.18 Debris of cells stimulate the 
body’s immune system by increasing the number of 
alveolar macrophages in the lung tissues. The first 
stage of immune defence in the body is carried out 
by M-1 alveolar macrophages through the process 
of phagocytosis.19 The debris of cells that have been 
phagocytosed by these macrophages will stimulate 
the secretion of various cytokines that help initiate 
an inflammatory reaction, one of which is IL-8.20 
Whenever these reactions occur excessively, one of 
the M-2 macrophage cells will play a role in regulating 
the inflammatory process. Macrophage cells express 
IL-10, which acts as an anti-inflammatory agent.21 The 
results of this study showed an increase in levels of 
interleukin-8 and a decrease in levels of interleukin-10 
in the treatment group. This change in interleukin 
levels would cause an excessive inflammatory reaction 
in the lung tissue.
The increased inflammatory response in lung 
tissue in the experiment group stimulates alveolar 
macrophage and the secretion of metalloprotein-8 
matrix, which is formed from the degranulation 
of polymorphonuclear neutrophils (PMNs) during 
the inflammatory reaction.22 Non-PMN cells that 
experience these reactions, such as epithelial cells of 
the human bronchi, also produce a metalloprotein-8 
matrix. This demonstrates the influence of 
the inflammatory process on the increase in 
metalloprotein-8 matrix in lung tissues.22 An excessive 
increase stimulates the degradation of type-2 collagen 
tissue found in the cells. This type of collagen is the 
main active protein in cartilage tissues. In the airways, 
it is abundant in the trachea, until it reaches the small 
bronchial tubes. Increased synthesis and secretion 
of type-2 collagen causes structural and functional 
disorders of cartilage. Inflammation due to foreign 
particles damages the bronchial wall and is one of 
the risk factors of pulmonary fibrosis.23 The increase 
in alveolar macrophage, metalloprotein-8 matrix and 
type-2 collagen that occurred in the experimental 
group of the current study can increase the risk of 
fibrosis in the lung tissue. 
The body’s ability to regulate inflammation is 
mainly through the secretion of anti-inflammatory 
cytokines, namely IL-10. These cytokines are produced 
by T helper 2 cells, which inhibit the activation of T 
helper 1 cells that play a role in increasing the number 
of macrophages in the lung tissue.24 In addition, IL-
10 is also needed to inhibit pathogen clearance and 
improve immunopathological conditions.25,26 This 
was evidenced in the current study by the increase 
Table 1: The results of the correlation-test for each group of male 
Wistar rats in a study assessing the levels of malondialdehyde, 
interleukin (IL)-8, IL-10, matrix metalloprotein-8 and type-2 
collagen following electronic-cigarette smoke exposure




IL-8† 0.995 - - - -
IL-10‡ 0.980 0.983 - - -
MMP-8§ 0.989 0.991 0.977 - -
Collagen 
type-2
−0.993 −0.992 −0.977 −0.991 -
Alveolar 
macrophage
0.995 0.995 0.994 0.994 −0.996
*MDA = malondialdehyde;  †IL-8 = interleukin-8;  ‡IL-10 = interleukin-10;  §MMP-8 = 
matrix metalloprotein-8.
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of various parameters of the inflammatory response 
in the group exposed to e-cigarette smoke, which 
was contrasted with the control group results. Each 
parameter shows a relationship in the inflammatory 
response process caused by exposure to e-cigarette 
smoke, which forms a molecular pathway for lung 
tissue damage.
Conclusion
Exposure to e-cigarette smoke increases free radicals 
in the airways through increased malondialdehyde. 
This causes modifications in pro-inflammatory 
cytokines found in the lung tissue, such as IL-6 and IL-
8, resulting in changes in the metalloprotein-8 matrix 
and commencing type-2 collagen degradation. Hence, 
this study showed a molecular pathway through its 
short-term negative impact caused by e-cigarette 
smoke that modifies the inflammatory process in 
the lung tissue and triggers the onset of lung tissue 
damage.
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conveyed to the authors via the online 
system. Revised manuscripts are subject 
to further review by the original reviewers 
and the responsible subject editors. The 
final decision as to acceptance or rejec-
tion lies with the Editor-in-Chief, with 
advice from the SQUMJ Editorial Board 
and Sultan Qaboos University's Academic 
Publications Board.
Editing
Papers selected for publication are edited 
by the SQUMJ Editorial Office for brevity, 
clarity, grammar, spelling and style. Brit-
ish/UK English spelling and punctuation 
are used. The Editorial Office has final 
approval over the version of the manu-
script to be published and certain changes/
modifications to the language and style of 
the text can be made without the authors’ 
agreement, as long as they do not impact 
the intended meaning or scientific content 
of the text. When the editing is extensive, 
with the possibility of altered meaning, 
queries are sent to the corresponding 
author by email. 
Proofs & Prints
The galley proof of an accepted article is 
emailed in PDF format to the correspond-
ing author for typographical checking only. 
It should be returned within 48 hours of 
receipt. The corresponding author will be 
provided with one copy of the issue per 
author of the manuscript. Since high-qual-
ity PDF reprints are downloadable from the 
SQUMJ web site, physical reprints are not 
issued. The full text of all articles is also avail-
able in PubMed and the abstracts in Scopus.
Checklist for 
Authors
• Manuscript conforms to ICJME Uni-
form Requirements?
• Standard Covering Letter uploaded and 
all required sections completed? 
• Abstract has required length and sec-
tions? Keywords provided? 
• Arabic translations of title, author-
names, abstract and keywords provided 
(if one author is Arabic-speaking)?
• Manuscript conforms to SQUMJ’s style, 
length and formatting requirements?
• Tables, drawings, charts and photo-
graphs placed after the article text and 
in editable format? 
• References in the Journal’s exact style? 
• All sources acknowledged, ethical per-
mission and patient consent received, 






index.asp and also from: www.edmgr.
com/squmj Author submission page.
This form covers Declaration of Author 
contributions, Source of Funding, Cop-
yright Transfer and Declaration of Con-
flict of Interest. The signature of the cor-
responding author at the bottom of this 
form certifies compliance with all sections. 
Manuscripts will not be processed until 
the corresponding author has completed 
this form and uploaded it along with the 
manuscript to SQUMJ at: www.edmgr.
com/squmj/ 
To: The Editor-in-Chief, SQU Medical Journal, 
College of Medicine & Health Sciences, 
Sultan Qaboos University, Post Box 35, PC 123 
Al-Khod,  Oman. 
Please find enclosed my/our paper entitled: 
Please consider it for publication in the SQUMJ. 
I/we certify that this paper has not been sub-
mitted for publication elsewhere and will not 
be submitted to another publication be it print 
or electronic. Likewise this paper has not been 
published elsewhere either in part or in its 
entirety in either print or electronic format. 
Upon acceptance of this manuscript, the copy-
right will transfer to SQUMJ.
Full Name & Signature Corresponding Author:
Full postal address of Corresponding Author:
E-mail address for correspondence:
COPYRIGHT TRANSFER 
In order that SQUMJ may disseminate the arti-
cles submitted and accepted by SQUMJ authors 
must transfer copyright to SQUMJ. If the article 
has multiple authors, the corresponding author 
takes responsibility for transferring the rights 
of all authors to SQUMJ by signing this form. 
However, all published articles will be licensed 
by SQUMJ under a Creative Commons Attribu-
tion License that allows others to freely share the 
work with an acknowledgement of the work's 
authorship and initial publication in this journal.
1. The authors hereby transfer all copy-
rights in and to the manuscript named 
above in all forms and media, now or 
hereafter known, to the SQUMJ and 
effective if and when the manuscript is 
accepted for publication in SQUMJ. 
2. The authors retain the following nonex-
clusive copyrights, to be exercised only 
after the manuscript has been published 
in online format on the SQUMJ website:
a) Reprint the manuscript in print collec-
tions of the author’s own writing. 
b) Present the manuscript orally in its 
entirety. 
c) Use the manuscript in theses and/or 
dissertations. 
d) Reproduce the manuscript for use in 
courses the author is teaching. (If the 
author is employed by an academic 
institution, that institution may also 
reproduce the manuscript for course 
teaching.) 
e) Distribute photocopies of the man-
uscript to colleagues, but only for 
non-commercial purposes. 
f ) Reuse figures and tables created by the 
author in future manuscripts the author 
writes. 
g) Post a copy of the manuscript on the 
author’s personal website, departmental 
website and/or the university’s intranet, 
provided a hyperlink to the manuscript 
on the SQUMJ website is included. 
h) In all the instances under clause 2a) 
through 2g) above, the author will give 
proper credit to the original publication 
in SQUMJ as follows: 
 This research was originally published in 
SQUMJ. Author(s). Title. Sultan Qaboos 
University Med J Year; vol:pp-pp.
3. The authors understand that if and when 
the manuscript is accepted for publica-
tion in SQUMJ it will be pre-published 
online in open access format one to 
two months before the issue appears in 
print. It will also appear in the SCOPUS 
Index in abstract format and in PubMed 
as a ‘Free PMC article’ (full text freely 
available).
4. The authors warrant that the manuscript 
(or its essential substance) has not been 
published other than as an abstract 
in any language or format and has not 




College of Medicine & Health Sciences
Sultan Qaboos University
P O Box 35, Postal Code 123 
Al-Khod, Muscat
Oman





2. Drafting the article or revising it criti-
cally 
3. Final approval of the version to be pub-
lished
4. Agreement to be accountable for all 
aspects of the work in ensuring that ques-
tions related to the accuracy or integrity 
of any part of the work are appropriately 
investigated and resolved.
Name of Corresponding Author:
Organisation:
Signature:
electronic publication consideration. 
5. The authors warrant that the manuscript 
does not contain any material the pub-
lication of which would violate any cop-
yright or other personal or proprietary 
right of any person or entity. 
6. The authors will obtain and include with 
the manuscript written permission from 
any respective copyright owners for the 
use of any textual, illustrative, or tabu-
lar materials that have been previously 
published or are otherwise copyrighted 
and owned by third parties. The authors 
agree that it is their responsibility to pay 
any fees charged for permissions. 
CONFLICT OF INTEREST 
DISCLOSURE 
SQUMJ is committed to ensuring the 
integrity of all its activities. The SQUMJ 
Conflict of Interest Policy requires each 
author to disclose all relevant financial and 
other interests that might be construed as 
resulting in an actual, potential or appar-
ent conflict in one’s role as contributor to 
SQUMJ, regardless of amount or value. 
Nothing in the disclosure statement shall 
be regarded as creating a presumption of 
impropriety in the existence of financial 
interests or other relationships. SQUMJ’s 
purpose is to inform peer reviewers and 
readers of the existence of financial rela-
tionships pertinent to the article in the 
interest of the full transparency of the peer 
review and publication processes. This 
form must be filled out and signed if and 
when any of the authors has any conflict of 
interest to disclose. It also needs to be filled 
out if none of the authors have a conflict of 
interest to declare. During the peer-review 
process the conflict(s) of interests will only 
be disclosed to editors and reviewers who 
will keep them confidential. If the paper is 
accepted for publication in SQUMJ, all dis-
closures will appear in both the print and 
online edition of the article in the Conflict 
of Interest section at the end of the article. 
Please tick the relevant box below: 
Either: 	No author of this paper has 
a conflict of interest, including specific 
financial interests, relationships and/or 
affiliations relevant to the subject matter 
or materials included in this manuscript. 
Or:  The authors certify that all conflicts 
of interest, as applicable to each author, 
including specific financial interests, rela-
tionships and/or affiliations relevant to 
the subject matter or materials included in 
this manuscript are disclosed in the man-
uscript, in the Conflict of Interest section. 
SOURCE OF FUNDING
Please complete here giving name of fund-
ing organisation and grant number for 
your work (or insert ‘Unfunded’).
CONTRIBUTION TO THE WORK 
I, the undersigned, corresponding author 
of this manuscript, agree to the conditions 
stated above and certify that I and my 
co-authors have contributed to all of the 
following:
1. Substantial contributions to conception 
and design, acquisition of data or analysis 
and interpretation of data
